Evaluation of the analgesic properties of zomepirac.
Zomepirac, an inhibitor of prostaglandin biosynthesis, was evaluated for analgesic activity in a number of pharmacological screens. In the acetylcholine writhing test, zomepirac was found to be more potent than codeine, pentazocine, aspirin, and acetaminophen and equivalent in potency to morphine. Zomepirac was inactive in a number of tests that detect narcotic agents, suggesting that the drug will not induce physical dependence. The possibility of a central nonnarcotic as well as a peripheral analgesic mechanism merits consideration.
D000700:Analgesics / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D002417:Cattle; D016861:Cyclooxygenase Inhibitors; D004347:Drug Interactions; D006614:Hindlimb / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D011758:Pyrroles / Q000494:pharmacology*; D011930:Reaction Time / Q000187:drug effects; D011957:Receptors, Opioid / Q000378:metabolism; D019966:Substance-Related Disorders / Q000503:physiopathology; D014046:Tolmetin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*
D000700:Analgesics; D016861:Cyclooxygenase Inhibitors; D011758:Pyrroles; D011957:Receptors, Opioid; D009270:Naloxone; D009020:Morphine; C020549:zomepirac; D014046:Tolmetin